يعرض 1 - 20 نتائج من 2,483 نتيجة بحث عن '"SMIT, E."', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1
    Report
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المصدر: Yeghaian , M , Bodalal , Z , Tareco Bucho , T M , Kurilova , I , Blank , C U , Smit , E F , van der Heijden , M S , Nguyen-Kim , T D L , van den Broek , D , Beets-Tan , R G H & Trebeschi , S 2024 , ' Integrated noninvasive diagnostics for prediction of survival in immunotherapy ' , Immuno-Oncology and Technology , vol. 24 , 100723 . https://doi.org/10.1016/j.iotech.2024.100723

  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    المصدر: Tohidinezhad , F , Bontempi , D , Zhang , Z , Dingemans , A M , Aerts , J , Bootsma , G , Vansteenkiste , J , Hashemi , S , Smit , E , Gietema , H , Aerts , H J W L , Dekker , A , Hendriks , L E L , Traverso , A & De Ruysscher , D 2023 , ' Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors ' , European Journal of Cancer , vol. ....

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal

    المصدر: Jebbink , M , de Langen , A J , Monkhorst , K , Boelens , M C , van den Broek , D , van der Noort , V , de Gooijer , C J , Mahn , M , van der Wekken , A J , Hendriks , L , Hashemi , S M S , Paats , M S , Dingemans , A C & Smit , E F 2023 , ' Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC ' , JTO Clinical and Research Reports , vol. ....

  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal

    المصدر: Hendriks , L E , Kerr , K M , Menis , J , Mok , T S , Nestle , U , Passaro , A , Peters , S , Planchard , D , Smit , E F , Solomon , B J , Veronesi , G , Reck , M , ESMO Guidelines Committee & Guidelines Committee , ESMO 2023 , ' Oncogene-addicted metastatic non-small-cell lung cancer : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ' , Annals of Oncology , vol. 34 , no. 4 , pp. 339-357 . https://doi.org/10.1016/j.annonc.2022.12.009

    وصف الملف: application/pdf

  17. 17
    Academic Journal

    المصدر: Hendriks , L E , Kerr , K M , Menis , J , Mok , T S , Nestle , U , Passaro , A , Planchard , D , Peters , S , Smit , E F , Solomon , B J , Veronesi , G , Reck , M , ESMO Guidelines Committee & Guidelines Committee , ESMO 2023 , ' Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ' , Annals of Oncology , vol. 34 , no. 4 , pp. 358-376 . https://doi.org/10.1016/j.annonc.2022.12.013

    وصف الملف: application/pdf

  18. 18
    Academic Journal

    المصدر: Zwierenga , F , van Veggel , B A M H , van den Berg , A , Groen , H J M , Zhang , L , Groves , M R , Kok , K , Smit , E F , Hiltermann , T J N , de Langen , A J & van der Wekken , A J 2023 , ' A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments ' , CANCER TREATMENT REVIEWS , vol. 120 , 102628 . https://doi.org/10.1016/j.ctrv.2023.102628

    وصف الملف: application/pdf

  19. 19
    Academic Journal
  20. 20
    Academic Journal

    Relation: Yu, H. A., Goto, Y., Hayashi, H., Felip, E., Chih-Hsin Yang, J., Reck, M., Yoh, K., Lee, S. -H., Paz-Ares, L., Besse, B., Bironzo, P., Kim, D. -W., Johnson, M. L., Wu, Y. -L., John, T., Kao, S., Kozuki, T., Massarelli, E., Patel, J. ,. Jaenne, P. A. (2023). HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy. Journal of Clinical Oncology, 41 (35), pp.5363-5378. https://doi.org/10.1200/JCO.23.01476.; http://hdl.handle.net/11343/337233